480 related articles for article (PubMed ID: 25721930)
21. RAS inhibitors' dose-dependent efficacy: myth or reality?
Taddei S
Curr Med Res Opin; 2015; 31(7):1245-56. PubMed ID: 25985327
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort.
Soto ME; van Kan GA; Nourhashemi F; Gillette-Guyonnet S; Cesari M; Cantet C; Rolland Y; Vellas B
J Am Geriatr Soc; 2013 Sep; 61(9):1482-8. PubMed ID: 24000874
[TBL] [Abstract][Full Text] [Related]
23. Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets.
Royea J; Hamel E
Geroscience; 2020 Oct; 42(5):1237-1256. PubMed ID: 32700176
[TBL] [Abstract][Full Text] [Related]
24. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.
Anderson C; Teo K; Gao P; Arima H; Dans A; Unger T; Commerford P; Dyal L; Schumacher H; Pogue J; Paolasso E; Holwerda N; Chazova I; Binbrek A; Young J; Yusuf S;
Lancet Neurol; 2011 Jan; 10(1):43-53. PubMed ID: 20980201
[TBL] [Abstract][Full Text] [Related]
25. Treatment options and considerations for hypertensive patients to prevent dementia.
Hernandorena I; Duron E; Vidal JS; Hanon O
Expert Opin Pharmacother; 2017 Jul; 18(10):989-1000. PubMed ID: 28532183
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin-Receptor Blockers and the Risk of Alzheimer´s Disease: A Meta-analysis.
Oscanoa TJ; Amado J; Vidal X; Romero-Ortuno R
Curr Rev Clin Exp Pharmacol; 2021; 16(1):73-78. PubMed ID: 32003701
[TBL] [Abstract][Full Text] [Related]
27. Meta-Analysis of the Effect of Dietary Sodium Restriction with or without Concomitant Renin-Angiotensin-Aldosterone System-Inhibiting Treatment on Albuminuria.
D'Elia L; Rossi G; Schiano di Cola M; Savino I; Galletti F; Strazzullo P
Clin J Am Soc Nephrol; 2015 Sep; 10(9):1542-52. PubMed ID: 26240299
[TBL] [Abstract][Full Text] [Related]
28. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
29. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E
Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945
[TBL] [Abstract][Full Text] [Related]
30. Budget impact analysis of increasing prescription of renin-angiotensin system inhibitors drugs to standard anti-hypertensive treatments in patients with diabetes and hypertension in a hypothetical cohort of Malaysian population.
Mohd-Tahir NA; Li SC
PLoS One; 2019; 14(2):e0212832. PubMed ID: 30817790
[TBL] [Abstract][Full Text] [Related]
31. Effects of Blood Pressure Lowering With Different Antihypertensive Agents on Cognitive Function and Plasma Brain-derived Neurotrophic Factor Levels: A Comparative Study.
Demir M; Gürol AO; Özyiğit RT; Üresin AY
J Cardiovasc Pharmacol; 2016 Jun; 67(6):538-43. PubMed ID: 26906033
[TBL] [Abstract][Full Text] [Related]
32. [The effect of angiotensin receptor blockers in cerebrovascular disorders and dementia: bonus in addition to the antihypertensive effect].
Kovács T
Ideggyogy Sz; 2014 May; 67(5-6):149-68. PubMed ID: 25087375
[TBL] [Abstract][Full Text] [Related]
33. The renin-angiotensin system and antihypertensive drugs in Alzheimer's disease: current standing of the angiotensin hypothesis?
Kehoe PG; Passmore PA
J Alzheimers Dis; 2012; 30 Suppl 2():S251-68. PubMed ID: 22330821
[TBL] [Abstract][Full Text] [Related]
34. Inhibiting the renin-angiotensin system: why and in which patients.
Berra K; Miller NH
J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
[TBL] [Abstract][Full Text] [Related]
35. Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study.
Edwards JD; Ramirez J; Callahan BL; Tobe SW; Oh P; Berezuk C; Lanctôt K; Swardfager W; Nestor S; Kiss A; Strother S; Black SE;
J Alzheimers Dis; 2017; 59(3):1113-1122. PubMed ID: 28731439
[TBL] [Abstract][Full Text] [Related]
36. Renin-angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review.
Kim G; Kim J; Lim YL; Kim MY; Baik SK
Hepatol Int; 2016 Sep; 10(5):819-28. PubMed ID: 26903052
[TBL] [Abstract][Full Text] [Related]
37. Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis.
Li X; Xuan W; Chen D; Gao H; Wang G; Guo Q; Wang Y; Song H; Cai B
J Alzheimers Dis; 2020; 78(4):1315-1338. PubMed ID: 33164932
[TBL] [Abstract][Full Text] [Related]
38. Angiotensins in Alzheimer's disease - friend or foe?
Kehoe PG; Miners S; Love S
Trends Neurosci; 2009 Dec; 32(12):619-28. PubMed ID: 19796831
[TBL] [Abstract][Full Text] [Related]
39. Effects of inhibitors of the renin-angiotensin system on reducing blood pressure and expression of inflammatory factors in CHD patients: A network meta-analysis.
Pang XF; Liu RM; Xia YF
J Cell Physiol; 2019 May; 234(5):5988-5997. PubMed ID: 30537058
[TBL] [Abstract][Full Text] [Related]
40. The renin-angiotensin system: a possible new target for depression.
Vian J; Pereira C; Chavarria V; Köhler C; Stubbs B; Quevedo J; Kim SW; Carvalho AF; Berk M; Fernandes BS
BMC Med; 2017 Aug; 15(1):144. PubMed ID: 28760142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
